Intracellular targets affected by zinc ions

Intracellular targets affected by zinc ions represent a broad spectrum of proteins, including enzymes, transcription factors, and signaling molecules, that are regulated by changes in the concentration of intracellular labile zinc (Zn2+). Zinc is an essential trace element that serves as a structural or catalytic cofactor for over 3,000 human proteins, including zinc finger transcription factors and enzymes like carbonic anhydrases and matrix metalloproteinases (PubMed: 23910373). In a pharmacological context, increasing intracellular zinc levels—often achieved through zinc ionophores like pyrithione or clioquinol—can inhibit the RNA-dependent RNA polymerase (RdRp) of various viruses, including SARS-CoV, thereby suppressing viral replication (PubMed: 21079686). Furthermore, zinc ions act as potent inhibitors of protein tyrosine phosphatases (PTPs), such as PTP1B, which enhances insulin signaling and has implications for diabetes treatment (PubMed: 15102326). Zinc also modulates apoptotic pathways by inhibiting caspases (e.g., Caspase-3, -6, and -9), thus playing a role in cell survival and neuroprotection (PubMed: 11592372). Because this "target" encompasses thousands of distinct proteins, therapeutic strategies often focus on specific tissues or disease states where zinc dysregulation is a hallmark, such as in neurodegeneration or immune dysfunction (PubMed: 25356595).

Other names

Zinc-binding proteomeZinc-regulated proteinsIntracellular zinc-sensitive targetsLabile zinc targets

Zinc ions modulate intracellular targets through several mechanisms: 1) Inhibition of enzymes such as viral RNA-dependent RNA polymerase and human protein tyrosine phosphatases (PubMed: 21079686, 15102326); 2) Structural stabilization of zinc finger motifs in transcription factors (PubMed: 23910373); 3) Allosteric modulation of signaling proteins; and 4) Inhibition of pro-apoptotic caspases (PubMed: 11592372). Zinc ionophores facilitate the transport of Zn2+ across the cell membrane to reach these targets (PubMed: 25356595).